Home › Funds › D. E. Shaw & Co › AMPH
D. E. Shaw & Co position in AMPH
AMPHASTAR PHARMACEUTICALS IN · Health Care
Latest position (Q2 2026)887.05K sh
Reported value held$17.90M
Portfolio Weight0.01%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 26.77K | $623.00K | New |
| Q1 2022 | 65.14K | $2.34M | Add |
| Q2 2022 | 61.73K | $2.15M | Reduce |
| Q3 2022 | 57.88K | $1.63M | Reduce |
| Q4 2022 | 57.95K | $1.62M | Hold |
| Q1 2023 | 137.31K | $5.15M | Add |
| Q2 2023 | 123.60K | $7.10M | Reduce |
| Q3 2023 | 100.17K | $4.61M | Reduce |
| Q4 2023 | 77.08K | $4.77M | Reduce |
| Q3 2024 | 23.66K | $1.15M | New |
| Q4 2024 | 118.85K | $4.41M | Add |
| Q1 2025 | 29.19K | $846.16K | Reduce |
| Q2 2025 | 293.93K | $6.75M | Add |
| Q3 2025 | 517.22K | $13.78M | Add |
| Q4 2025 | 557.07K | $14.92M | Add |
| Q1 2026 | 665.54K | $13.04M | Add |
| Q2 2026 | 887.05K | $17.90M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding AMPH
- Vanguard Group 2.61M sh · $69.85M · Q4 2025
- Marshall Wace 1.07M sh · $21.52M · Q2 2026
- Geode Capital Management 969.84K sh · $19.58M · Q2 2026
- Renaissance Technologies 525.10K sh · $10.60M · Q2 2026
- Goldman Sachs Group 505.36K sh · $10.20M · Q2 2026
- UBS Group AG 393.11K sh · $7.93M · Q2 2026
- Northern Trust Corp 370.99K sh · $7.49M · Q2 2026
- Charles Schwab Investment Management 310.18K sh · $6.26M · Q2 2026
- BlackRock Inc 6.83M sh · $6.19M · Q2 2026
- Royce & Associates 294.76K sh · $5.95M · Q2 2026
- Two Sigma Investments 248.12K sh · $5.01M · Q2 2026